Steve Schonfeld’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-100,000
Closed -$232K – 765
2017
Q4
$232K Buy
+100,000
New +$6.25M 0.02% 639

Other funds holding BMY

Steve Schonfeld's BMY Position: Q3 2026 in Review

Steve Schonfeld increased its Bristol-Myers Squibb (BMY) stake by 341% in Q3 2026, buying an estimated $1.93M and bringing the position to 39,404 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #1035.

Steve Schonfeld first reported a position in BMY in Q1 2016 and has held it in 38 quarters since. The position peaked at $52.9M in Q3 2025. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Steve Schonfeld held 39,404 shares of Bristol-Myers Squibb worth $2.46M as of Q3 2026.
  • Steve Schonfeld bought 30,467 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.93M.
  • Bristol-Myers Squibb made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1035 holding.
  • Steve Schonfeld first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 38 quarters since.
  • Steve Schonfeld's Bristol-Myers Squibb position peaked at $52.9M in Q3 2025.
  • 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.